Open AccessMutations in mitochondrial DNA associated with hypertension
Author(s) -
Xue Li,
Hong Chen,
Yanzi Meng,
Yan Wang,
Zhongqiu Lu,
Jianxin Lü,
MinXin Guan
Publication year - 2011
Publication title -
yichuan
Language(s) - English
Resource type - Journals
ISSN - 0253-9772
DOI - 10.3724/sp.j.1005.2011.00911
Subject(s) - mitochondrial dna , transfer rna , mutation , genetics , biology , mitochondrion , gene , mechanism (biology) , human mitochondrial genetics , economic shortage , oxidative phosphorylation , biochemistry , rna , philosophy , linguistics , epistemology , government (linguistics)
Mutations in mitochondrial DNA (mtDNA) are one of the molecular bases of hypertension. Among these, the tRNAMet A4435G, tRNAMet/tRNAGln A4401G, tRNAIle A4263G, T4291C and A4295G mutations have been reported to be associated with essential hypertension. These mutations alter the structure of the corresponding mitochondrial tRNAs and cause failures in tRNA metabolism. These shortages of these tRNAs lead to an impairment of mitochondrial protein synthesis and a failure in the oxidative phosphorylation function. These result in a deficit in ATP synthesis and an increase of generation of reactive oxygen species. As a result, these mitochondrial dysfunctions may contribute to the development of hypertension. Furthermore, the tissue specificity of these pathogenic mtDNA mutations might be associated with tRNA metabolism and nuclear modifier genes. These mtDNA mutations should be considered as inherited risk factors for future molecular diagnosis. Thus, these findings provide new insights into the molecular mechanism, management and treatment of maternally inherited hypertension. This review summarized the association between mtDNA mutations and hypertension.